Introducing the T1GER study.
A clinical research study for people ages 6–21 who are newly diagnosed with type 1 diabetes.
This clinical research study is being conducted to
with type 1 diabetes.
determine the safety and efficacy of an investigational medication in children and young adults newly diagnosed
Each patient will be evaluated to determine his or her eligibility to participate in the study. Those who qualify will receive the investigational medication or a placebo, along with study-related medical exams and laboratory tests, at no cost. Compensation may also be available to assist with travel expenses. Learn more about the T1GER study.
Find a participating site